Company Filing History:
3 out of 454 
2 out of 3 Years Active: 2023-2025
Title: Antonio Alcami Pertejo: Innovator in Therapeutic Solutions
Introduction
Antonio Alcami Pertejo is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for autoimmune and inflammatory diseases. His innovative work focuses on improving existing treatments to enhance their efficacy and reduce side effects.
Latest Patents
Antonio Alcami Pertejo holds a patent for "Etanercept variants with improved therapeutical effect." This invention provides improved Etanercept variants that include one (A105E) or preferably two (A105E/L106F) amino acid substitutions in the original amino acid sequence. These variants effectively inhibit TNF activity while not neutralizing human LTα (hLTα). This makes them a promising alternative for clinical use in treating autoimmune or inflammatory diseases, as they mitigate the side effects associated with the original Etanercept molecule while maintaining TNF blocking activity. He has 1 patent to his name.
Career Highlights
Antonio Alcami Pertejo is affiliated with the Consejo Superior de Investigaciones Científicas, where he conducts his research and development work. His career is marked by a commitment to advancing therapeutic solutions that address critical health challenges.
Collaborations
He collaborates with esteemed colleagues such as Sergio Martín Pontejo and Carolina Sánchez Fernández, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Antonio Alcami Pertejo is a distinguished inventor whose work in developing improved Etanercept variants showcases his dedication to enhancing therapeutic options for patients. His contributions are vital in the ongoing fight against autoimmune and inflammatory diseases.